Skip to main content
. 2019 Feb 11;38(22):4412–4424. doi: 10.1038/s41388-019-0712-y

Fig. 4.

Fig. 4

APSCE recreated phenotypes associated with clinical treatment resistance in castration-resistant prostate cancer. a Comparison of OSN expression and development of castration-resistant prostate cancer (CRPC) (t-test, p = 0.0016). b Measurement of testosterone (T) levels in FM, steroid-depleted medium (SDM) and APSCE medium including in water (CTRL). c Expression of PSA, KLK2, TMPRSS2 and NKX3.1 was measured by qPCR in CWR22Rv1 cells cultured in FM, SDM and APSCE. Data is represented as fold change of FM experimental arm. Data represents at least three independent experiments ± SEM